• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

CMS Awards Startup Amino Access to Physician-Level Medicare Claims Data

by HITC Staff 12/16/2015 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

digital health startup amino

Amino, a digital health startup connecting people to doctors, today announced that it has achieved Qualified Entity (QE) Status under the Centers for Medicare & Medicaid Services’ (CMS) data sharing program and will be the first for-profit company to receive a complete set of national, physician-level claims data from Medicare parts A, B, and D.

These CMS claims will be added to Amino’s expanding database – already more than 5 billion health care interactions representing 188 million Americans – that powers a free service to help Americans make informed health care decisions, starting with the doctors they choose.

The QE program, established in the Affordable Care Act to increase transparency and empower consumers with information on health care practices and providers, has rigorous guidelines as it relates to the handling and use of sensitive health care data on nearly 50 million Americans under Medicare. Amino, as a company with a mission to give the clearest picture of health care for all Americans, has surpassed these guidelines and will be receiving data, totaling around 3 billion Medicare claims data under parts A, B, and D per year since 2009, in early 2016.

In order to achieve QE status, Amino is implementing the highest levels of data security and patient privacy, while also providing consumers with meaningful information to help them make informed decisions. With sensitive handling of both de-identified and identified patient data at a national level, Amino is able to track health care longitudinally to shed light on health conditions and procedures over time and across providers.

In addition to making valuable health care insights more accessible to everyone, Amino recognizes a huge opportunity to help define what quality care means for consumers with the newfound Medicare data. As such, it has convened a committee of prominent stakeholders representing patients, providers, payers, employers, and suppliers, which is under review to become one of the nation’s first Consensus Based Entities (CBE) authorized to review and endorse quality-of-care measures using Amino’s unprecedented commercial and Medicare data.

Amino launched in October 2015 to help people make confident, data-driven health care decisions. Its first service, available at Amino.com, helps people find doctors experienced with their needs and suitable to their preferences. The company will soon provide answers to a wider range of health care questions, including procedures, treatment options, and costs.

 

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Amino

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |